Sorry, You Probably Cannot Get MDMA Through Telehealth
Lykos’ current application is based on MDMA-assisted therapy, and FDA will almost surely require that patients take the drug in a clinical setting.

Lykos’ current application is based on MDMA-assisted therapy, and FDA will almost surely require that patients take the drug in a clinical setting.

The telemedicine extension is not just for psychedelics; easing these restrictions means relaxing them for other controlled substances as well.

Interesting empirical studies, policy analyses, and editorials on pharma, health law, and policy issues from August 2020.
